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Abstract 
BACKGROUND: Mental disorders are the most common problems in the life of People Living with HIV/AIDS 
(PLWHA). The frequency in which HIV/AIDS and mental health problems co-exist, and the complex bi-directional 
relationship between them. Several biological, distress psychological and social dysfunction factors are 
associated with mental disorders in PLWHA.  
AIM: To analyse the relationship between the screening of mental disorders using General Health Questionnaire-
12 scores and CD4 counts of People Living with HIV/AIDS with Anti-Retroviral Treatment. 
METHODS: This was a correlative analytical study with a cross-sectional approach using the General Health 
Questionnaire-12 (GHQ-12) instrument to assess screening mental disorders and the CD4 count. This research 
was conducted in February 2019 – April 2019 at an HIV/AIDS outpatient clinic. As many 33 subjects were divided 
into inclusion criteria; participant confirmed HIV seropositivity in stage II or III were undergoing ARV treatment, 
ranged in age between 25-49 years. The duration of HIV disease was ≤ four years, and the duration of ARV 
treatment was ≥ six months and informed consent to participate in the study. The patient who had mental 
disorders and currently drugs user was excluded from this study.  
RESULTS: There was an association found between change in CD4 and screening mental disorders at univariate 
analysis among the study participants, whether on antiretroviral treatment. The correlation between the total 
GHQ-12 scores as a screening of mental disorders and CD4 counts indicated to result in a significant negative 
correlation, r = -0.670 with p = 0.001. 
CONCLUSION: Screening mental disorders using General Health Questionnaire-12 from the results of this study 
shows that it is important to do for PLWHA because with low CD4 levels as biomarkers the progression of HIV 
infection affects psychological distress and social dysfunction in people living with HIV who have the potential for 
symptoms of mental disorders. 
 
 
 
Introduction 
 
Acquired Immune Deficiency Syndrome 
(AIDS) is a collection of symptoms or diseases 
caused by decreased immunity due to infection with 
the HIV which belongs to the retroviridae family. AIDS 
is the final stage of HIV infection. People with HIV and 
AIDS abbreviated as PLWHA are people who have 
been infected with the HIV virus [1]. 
People living with HIV/AIDS (PLWHA) will be 
vulnerable to the emergence of psychological 
problems and social problems, then it will have an 
impact on the emergence of mental disorders that 
arise not only when knowing HIV-infected status, but 
also changes in clinical conditions or clinical 
deterioration, namely the progression of HIV infection 
to AIDS. Quite several studies have examined the 
relationship between clinical development of HIV 
infection as measured by biomarkers of Cluster of 
Differences 4 (CD4) count, viral load count and 
psychological distress in people living with HIV [2].
 
A study conducted by Andrew in 2012 at 
Lagos University Teaching Hospital (LUTH) in West 
Africa of 300 people living with HIV in the age range of 
18-60 years using the General Health Questionnaire 
(GHQ-12) instrument. It was found that the mean 
score of psychological distress was 4.6 (± 1.58). In the 
study also found a positive correlation between GHQ-
12 scores and socio-demographic (unemployment, 
unmarried status and lack of family support) in 
PLWHA who were significantly related (p < 0.05) [3].
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A descriptive cross-sectional study by Ezeh 
and friends in 2017 at Shika Hospital, Nigeria 
analysed the socio-demographics of people with 
HIV/AIDS with psychological distress who received 
antiretroviral therapy. Appraisal of psychological 
distress using GHQ-12 obtained total results that 
experienced psychological distress as much as 78%, 
with details of 16.2% with severe distress, 25.1% with 
moderate distress and 36.7% with severe distress. 
Women (65%) were more likely to experience 
psychological distress than men (35%) OR = 3.5 CI 95 
per cent. The high level of psychological distress 
found is related to many factors related to problems in 
the family, bad culture, stigma, isolation from society 
and poverty to PLWHA [4].
 
In a different study by Farah M and friends 
conducted in Bandar Abbas Behavioral Diseases 
Counseling Center in
 
2012 using the General Health 
Questionnaire-28 (GHQ-28) as a measure of risk 
screening for mental disorders in PLWHA, with a 
sample of 95 ODHA. In the study, it was found that 
there was no significant relationship between mental 
disorders in PLWHA with the clinical stage of 
HIV/AIDS, gender, area of residence, marital status, 
education status, employment status, and history of 
drug use [5].
 
Based on this background, through a 
literature review, no similar research has ever been 
carried out in Indonesia. So, through this study, the 
researchers wanted to find out whether there was a 
correlation between psychological distress scores, 
social dysfunction scores, total General Health 
Questionnaire-12 (GHQ-12) scores and CD4 levels in 
people with HIV/AIDS who were undergoing Anti-
Retroviral treatment in Indonesia. 
 
 
Methods 
 
This cross-sectional study was conducted in 
HIV/AIDS outpatient clinic, Haji Hospital, Medan, 
Indonesia, from February to April 2019 among 33 
people living with HIV/AIDS (PLWHA) collected using 
the consecutive sampling method. 
The inclusion criteria for the study were 
participant confirmed HIV seropositivity in stage II or 
III undergoing ARV treatment, ranged in age between 
25-49 years. The duration of HIV disease was ≤ four 
years, and the duration of ARV treatment was ≥ six 
months and informed consent to participate in the 
study. A patient who had mental disorders and 
currently drugs user was excluded in this study.  
Participation in this study was voluntary and 
written informed consent was obtained from each 
study participant after a detailed description of study 
objectives and procedures was provided. Privacy and 
confidentiality of the respondent were strictly 
protected. Health Research Ethical Committee 
approved this study, Faculty of Medicine of 
Universitas Sumatera Utara, Medan, Indonesia 
(No:245/TGL/KEPK FK USU-RSUP HAM/2019). 
The GHQ-12 is a self‑administered screening 
test, which is sensitive to the presence of psychiatric 
disorders in individuals presenting in primary care 
settings and non‑psychiatric clinical settings. The 
GHQ is not designed to detect symptoms that occur 
with specific psychiatric diagnose; rather; it provides a 
measure of overall psychological health or wellness. 
The GHQ has reasonable test-retest reliability and 
both content validity and constructs validity. In the 
present study, the shorter version containing 12 items 
– the GHQ‑12 – was used. The GHQ‑12 has a 
sensitivity of 89% and specificity of 80% [6].
 
 
Statistic analysis 
Sapphiro- Wilk test was performed to 
determine the normality distribution of the data. 
Furthermore, Pearson test was conducted for 
analysis. Both of these tests were carried out via 
SPSS 24 program. 
 
 
Results 
 
Socio-demographic characteristics of 33 study 
participants at the HIV clinic in Haji Hospital, Medan, 
Indonesia, between February – April 2019. 
Table1: Socio-demographic characteristics  
Characteristics mean ± SD  N (%) 
Age in years 35.06 ± 6.55*  
 Gender  
 Male  
 Female  
 
 
 
18 (54.50%) 
15 (45.50%) 
Stage of HIV 
 Stage II 
 Stage III 
  
17 (51.50%) 
16 (48.50%) 
Marital status 
 Single  
 Married  
  
15 (45.50%) 
18 (54.50%) 
Educational level 
 Elementarry  
 Junior High  
 Senior High  
 Graduation ect. 
  
3 (9.10%) 
4 (12.10%) 
13 (39.40%) 
13 (39.40%) 
Occupational status 
 Work  
 Jobless  
  
18 (54.50%) 
15 (45.50%) 
Duration of infection in a month 27.15 ± 10.54*  
Duration of ARV in months 25.67 ± 10.27*  
Psychological distress score  13.06 ± 1.95*  
Social dysfunction score  13.06 ± 1.75*  
Total GHQ-12 score  26.12 ± 3.16*  
CD4 count 281.91 ± 87.80*  
*Shapiro-Wilk test p > 0,05. 
 
The mean age of the subjects was found out 
to be 35.06 and standard deviation of 6.55 years. 17 
subject (54.50%) cases were males, and 16 subjects 
(45.50%) cases were females. The most common 
marital status is single to many as 18 subjects 
(54.50%). The subject in stage II was the most 
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subjects who participated in this study (51.50%). The 
most education level recorded is in senior high school 
and Graduation with 13 subjects (39.40%). Moreover, 
most occupational status is working for 18 subjects 
(54.50%). The mean time diagnosed with HIV is 
27.15, with a standard deviation of 10.54 months. The 
mean for obtaining ARV therapy is 25.67, with a 
standard deviation of 10.27 months. These data were 
normally distributed, referred to the results of the 
Shapiro-Wilk test with p > 0.05. 
The mean psychological distress scores 
obtained 13.06 and a standard deviation of 1.95. 
Based on the results of the data normality test using 
Shapiro-Wilk, the data were normally distributed with 
p = 0.12 (p > 0.05). The mean social dysfunction 
scores obtained 13.06 and a standard deviation of 
1.75. From the results of the normality test using 
Shapiro-Wilk, it was found that the value of p = 0.25 (p 
> 0.05), so it can be concluded that the data is 
normally distributed. 
The overall mean of total General Health 
Questionnaire-12 (GHQ-12) score was 26.12 and 
standard deviation of 3.16. The data were normally 
distributed with p = 0.90 (p > 0.05). The overall mean 
of CD4 count was 281.97 and standard deviation of 
87.80. The data were normally distributed with p = 
0.26 (p > 0.05). The mean of CD4 count in this study 
was obtained 281.97 with a standard deviation of 
87.80. Based on the results of the data normality test 
using Shapiro-Wilk, the data were normally distributed 
with p = 0.26 (p > 0.05). 
  
The Correlation between Psychological 
 Distress Score and CD4 Count 
Table 2 in this study obtained the results of 
the Pearson correlation test between psychological 
distress scores using GHQ-12 and CD4 count in 
people living with HIV/AIDS who were undergoing 
ARV treatment statistically significantly showed a 
negative correlation of 0.576 with moderate 
correlation strength (r = 0.4 - <0.6), p = 0.001. With 
interpretation, the lower CD4 count means higher 
psychological distress in people living with HIV/AIDS. 
Table 2: The correlation between psychological distress score 
and CD4 count 
CD4 count 
Psychological distress r = - 0.576 
score p = 0.001* 
n = 33  
*Pearson Correlation Test. 
 
The Correlation between Social 
 Dysfunction Score and CD4 Count. 
Based on the Table 3, it can be seen that the 
correlation between the Social Dysfunction Score and 
CD4 Count of PLWHA who are undergoing ARV 
therapy is statistically significant showing a negative 
correlation of 0.568 with moderate correlation strength 
(r = 0.4 - <0.6), p = 0.001 With interpretation, the 
lower of CD4 count means a higher incidence of 
social dysfunction in people living with HIV/AIDS. 
Table 3: The Correlation between Social Dysfunction Score and 
CD4 Count 
 CD4 count  
 Social dysfunction r = - 0.568 
 score p = 0,001 
 n = 33  
*Pearson Correlation Test. 
 
The Correlation between Total GHQ-12 
 Score and CD4 Count. 
Based on table 4 in this study obtained 
Pearson correlation between the total score of the 
General Health Questionnaire-12 (GHQ-12) and CD4 
count in people living with HIV/AIDS who were 
undergoing ARV therapy statistically significantly 
showed a negative correlation of 0.670 with strong 
correlation strength (r = 0.4 - < 0.6), p = 0.001. 
Table 4: The Correlation between Total GHQ-12 Score and CD4 
Count 
CD4 count  
Total GHQ-12 score r = -0.670  
p = 0,001  
n = 33  
*Pearson Correlation Test. 
 
 
Discussion 
 
Socio-demographic characteristics obtained 
by the mean age in this study were 35.06 years and 
standard deviation of 6.55 years. Based on data from 
the Indonesian Ministry of Health's Directorate 
General, it was found that the highest prevalence for 
people with HIV/AIDS and those at risk of acquiring 
HIV infection was in productive age, 25-49 years. The 
most common marital status is married as many as 18 
subjects (54.50%) [7].
 
The mean duration of infection HIV was 27.15 
(SD = 10.54) months. The duration of diagnosed 
affects psychological distress and social dysfunction 
and also on decreased CD4 levels in people living 
with HIV/AIDS.  
The study conducted by Rachel Ramovha 
said that people who had just learned that they were 
infected with HIV would have various responses such 
as feeling unsure, denial, anger, anxiety, depression 
and to think of suicide [8].
 
The mean duration of ARV therapy was 25.67 
(SD = 10.27) months. The study of Andrew found that 
the duration of ARV therapy showed a negative 
correlation with the GHQ-12 score (p < 0.05). Based 
on the guidelines for ARV treatment by the Indonesian 
Ministry of Health in 2014, it was stated that PLWHA 
who had started ARV treatment desperately needed 
control and regular follow-up. In the first six months, 
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there will be concerns about the possibility of the risk 
of unexpected side effects or Immune Reconstitution 
Inflammatory Syndrome (IRIS) [9].
 
The study by G. Ironson et al for 4-years 
longitudinal prospective design of 177 PLWHA with 
ARV therapy showed that psychosocial factors with 
high BDI scores, high neurohormone factors such as 
cortisol and Norepinephrine (NE) will significantly 
influence the progression of HIV infection to AIDS, a 
significant decrease in CD4 levels and an increase in 
the number of viruses (viral load). With these 
considerations, this study needs to control the 
duration of antiretroviral therapy for more than six 
months and limited to less than four years [10]. 
The study by Jenifer Attonito in 2014 
concluded that PLWHA who adhered to ARV therapy 
could significantly mediate the psychosocial incidence 
and progression of HIV infection as measured by CD4 
levels and viral load (p = 0.001) [11].
 
In another study by Pleasure Atok Ngum et al. 
of 300 PLWHA in Cameroon, the prevalence of 
PLWHA with symptoms of mental disorders was 
26.7% with mean duration ARV therapy 47.6 ± 36.8 
months. The results showed that there was no 
significant relationship between the duration of 
diagnosis of HIV infection and symptoms of mental 
disorders (p = 0.65) and there was no significant 
relationship between the duration of getting ARV 
therapy and symptoms of mental disorders (p = 0.71) 
in PLWHA [12]. 
The mean of psychological distress obtained 
13.06 (SD = 1.95). In another study conducted by 
Andrew at Lagos University Teaching Hospital 
(LUTH), West Africa of 300 PLHIV who was on ARV 
therapy in the age range of 18-60 years using the 
General Health Questionnaire (GHQ-12) instrument 
with bimodal scale (0, 0, 1, 1) and cut off value 0/1. It 
was found that the mean of psychological distress 
was 4.60 (SD = 1.58) [3]. Both studies showed the 
same thing as psychological distress in PLWHA who 
were on ARV treatment. The mean score of social 
dysfunctions with the GHQ-12 instrument in this study 
was 13.06 (SD = 1.75). The same mean value 
between psychological distress scores and social 
dysfunction score indicates that both psychological 
distress and social dysfunction in this study equally 
affect PLWHA. The mean of the total GHQ-12 score in 
this study was 26.12 (SD = 3.16), which indicates the 
high score of GHQ-12. Based on the study of Ira in 
the validity and reliability of the GHQ-12 at the 
University of Indonesia found the cutoff value of 7/8 
has identified a symptom of mental disorder in the 
subject [6]. The mean of CD4 levels in this study was 
obtained at 281.97, with a standard deviation of 87.80. 
The decrease in CD4 counts is related to 
psychological distress and social dysfunction. CD4 
levels, as biological parameters, will affect the process 
of HIV infection along with clinical assessment. CD4 
monitoring can be used to initiate ARV therapy or drug 
replacement for PLWHA. 
This study obtained the results of the Pearson 
correlation test between psychological distress scores 
using GHQ-12 and CD4 count in people living with 
HIV/AIDS who were undergoing ARV treatment 
statistically significantly showed a negative correlation 
of 0.576 with moderate correlation strength (r = 0.4 - < 
0.6), p = 0.001. With interpretation, the lower CD4 
count means higher psychological distress in people 
living with HIV/AIDS. 
A study by Weinstein and Li 2016 in the 
United States by analysing 23 studies on 
psychological distress relationships with the 
progression of HIV infection in people living with HIV 
who were on ARV treatment. The results show that 
high stress is linked to the clinical deterioration 
conditions of HIV infection associated with 
hypothalamic-pituitary-adrenal (HPA) axis activation 
and sympathetic adrenal-medullary (SAM) systems 
[2].
 
Based on the result on this study, the 
correlation between the social dysfunction score and a 
CD4 count of PLWHA who is undergoing ARV therapy 
is statistically significant showing a negative 
correlation of 0.568 with moderate correlation strength 
(r = 0.4 - < 0.6), p = 0.001. With interpretation, the 
lower CD4 count means a higher incidence of social 
dysfunction in people living with HIV/AIDS. A study by 
Prison showed that psychosocial factors using the 
Beck Depression Inventory (BDI) measurement 
instrument and neurohormonal factors affected the 
progression of HIV infection based on biological 
parameters using CD4 count and viral load. 
Psychosocial factors with high BDI scores were 
obtained, high neurohormone factors such as cortisol 
and Norepinephrine (NE) will significantly affect the 
progression of HIV infection to AIDS, a significant 
decrease in CD4 levels and an increase in viral load 
[10]. 
This study obtained Pearson correlation 
between the total score of the General Health 
Questionnaire-12 (GHQ-12) and CD4 count in people 
living with HIV/AIDS who were undergoing ARV 
therapy statistically significantly showed a negative 
correlation of 0.670 with strong correlation strength (r 
= 0.4 - < 0.6), p = 0.001. Both constructs in GHQ-12, 
psychological distress and social dysfunction 
constructs can be interpreted as screening for mental 
disorders that are significantly affected by CD4 count 
as biomarkers of the progression of HIV infection in 
PLWHA. 
People living with HIV/AIDS are associated 
with psychological and social problems. These 
individuals are faced with various stigmas to show 
changes in psychosocial character. PLWHA will feel 
uncomfortable feelings because of the fear of the 
future, the next life which is full of uncertainty, to the 
quality of life and hopes of the future that are 
considered destroyed [13].
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Physiological mechanisms that regulate 
stress can explain how stress in the immune function 
in HIV infection is interconnected and inseparable. 
First is through the mechanism of HPA (hypothalamic-
pituitary-adrenal) activity through corticotropin-
releasing factors (CRF). HIV infection affects the work 
of astrocytes and microglia to more actively produce 
and secrete pro-inflammatory interleukin-1 beta 
cytokines (IL-1β, interleukin-6 (IL-6) and tumour 
necrosis factor (TNF-α), production of reactive oxygen 
species (ROS) The proinflammatory cytokine together 
with serotonin, norepinephrine and acetylcholine 
which is a stress mechanism in the second pathway 
will affect the paraventricular nucleus (PVN) in the 
hypothalamus, then produce signaling molecules in 
the form of corticotropin-releasing factors (CRF) finally 
released at the end of the capillary arteries in the 
portal pituitary venous plexus which becomes the 
estuary of the anterior pituitary gland CRF then 
activates the basophil receptor in the anterior pituitary, 
induces postopias proopiomelanocortin polyprotein 
(POMC) to produce ACTH (adrenocorticotropic 
hormone), α, β, an melanocytes stimulating hormone 
(MSH), and β endorphins. ACTH will increase cortisol 
production as a stress hormone through its stimulation 
in the adrenal cortex. Cortisol is a glucocorticoid, a 21-
carbon steroid produced in the fasciculation zone of 
the adrenal cortex. CRF also induces somatostatin 
and dopamine secretion by the hypothalamus. The 
immunosuppressive effect on the lymphoreticular 
system on distress will subsequently cause PLWHA to 
fall into mental disorders [14], [15].
 
Screening mental 
disorders using General Health Questionnaire-12 from 
the results of this study shows that it is important to do 
for PLWHA because with low CD4 levels as 
biomarkers the progression of HIV infection affects 
psychological distress and social dysfunction in 
people living with HIV who have the potential to get 
mental disturbances.
 
In conclusion, this study indicated a significant 
correlation between screening mental disorders using 
GHQ-12 and a CD4 count of people living with 
HIV/AIDS with antiretroviral treatment in HIV/AIDS 
outpatient clinic, Haji Hospital, Medan. The results 
showed strong correlation strength (r = 0.670), with 
negative direction (r = 0.6 - <0.8), p = 0.001. It 
indicates that the decrease in CD4 count will increase 
the risk of symptoms of mental disorders for PLWHA. 
Screening for mental disorders needs to be done in 
HIV/AIDS outpatient clinic quickly detect symptoms of 
mental disorders of PLWHA. 
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